PIDILITIND - IntraDay Trade Analysis with Live Signals

Last Updated Time : 20 Dec 25, 07:03 am

IntraDay Trade Rating: 3.6

📊 Analysis: PIDILITIND is trading at ₹1,462, slightly below both 50 DMA (₹1,479) and 200 DMA (₹1,491), reflecting short-term weakness. RSI at 42.1 indicates neutral-to-weak momentum, while MACD (-5.13) confirms bearish bias. Intraday volume (2,68,718) is lower than the 1-week average (3,42,910), suggesting reduced participation today. Fundamentals remain strong with ROCE (30.5%) and ROE (23.2%), though valuations are expensive (P/E 66.7, PEG 3.27).

💡 Optimal Buy Price: ₹1,455–₹1,465 (near support zone).

🎯 Profit-Taking Levels: ₹1,490 – ₹1,510 (short-term resistance).

🛡️ Stop-Loss: ₹1,440 (below intraday support).

⏱️ Exit Strategy if Already Holding: Exit intraday if price fails to sustain above ₹1,460 with weakening momentum. If RSI drops below 40 and MACD remains negative, consider closing positions near ₹1,455–₹1,460. If momentum improves with volume pickup, hold until ₹1,490–₹1,510.

Positive

• 📈 ROCE (30.5%) and ROE (23.2%) show strong efficiency.
• 💡 Debt-to-equity 0.03 reflects near debt-free balance sheet.
• ⚡ Dividend Yield 0.69% provides modest shareholder returns.
• 📊 EPS ₹21.8 supports earnings strength.

Limitation

• 📉 Current price below DMA 50 & DMA 200, reflecting bearish trend.
• 📊 High P/E (66.7) and PEG (3.27) indicate expensive valuation.
• 📉 Volume below average, limiting intraday momentum strength.

Company Negative News

• ⚠️ FII holding reduced (-0.05%), showing foreign investor caution.
• 📉 Quarterly PAT declined from ₹650 Cr. to ₹586 Cr.

Company Positive News

• ✅ Quarterly profit variation +8.10% YoY shows earnings growth trend.
• 💡 Strong fundamentals with high efficiency and low debt.

Industry

• 🏭 Industry PE at 26.6 vs stock PE 66.7, showing premium valuation.
• 📊 Specialty chemicals sector remains resilient with long-term demand outlook.

Conclusion

⚖️ PIDILITIND shows strong fundamentals but weak short-term technicals. Intraday traders should be cautious, buying near support (₹1,455–₹1,465) with tight stop-losses. Upside is possible toward ₹1,490–₹1,510 if momentum improves. Long-term investors may remain cautious due to high valuations, but intraday trades can be attempted defensively today.

Would you like me to extend this into a peer benchmarking overlay comparing PIDILITIND with other specialty chemical stocks, or prepare a sector rotation basket scan to highlight stronger intraday momentum candidates?